• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格列本脲稳定性增强的三元固体分散体:制备方法对其理化性质的影响

Stability-Enhanced Ternary Solid Dispersions of Glyburide: Effect of Preparation Method on Physicochemical Properties.

作者信息

Barghi Leila, Vekalati Afshin, Jahangiri Azin

机构信息

Department of Pharmaceutics, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.

School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.

出版信息

Adv Pharmacol Pharm Sci. 2023 May 11;2023:2641153. doi: 10.1155/2023/2641153. eCollection 2023.

DOI:10.1155/2023/2641153
PMID:37215486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10199792/
Abstract

INTRODUCTION

Limited aqueous solubility and subsequent poor absorption and low bioavailability are the main challenges in oral drug delivery. Solid dispersion is a widely used formulation strategy to overcome this problem. Despite their efficiency, drug crystallization tendency and poor physical stability limited their commercial use. To overcome this defect, ternary solid dispersions of glyburide: sodium lauryl sulfate (SLS) and polyethylene glycol 4000 (PEG), were developed using the fusion (F) and solvent evaporation (SE) techniques and subsequently evaluated and compared.

MATERIALS AND METHODS

Physicochemical and dissolution properties of the prepared ternary solid dispersions were evaluated using differential scanning calorimetry (DSC), infrared spectroscopy (FTIR), and dissolution test. Flow properties were also assessed using Carr's index and Hausner's ratio. The physical stability of the formulations was evaluated initially and after 12 months by comparing dissolution properties.

RESULTS

Formulations prepared by both methods similarly showed significant improvements in dissolution efficiency and mean dissolution time compared to the pure drug. However, formulations that were prepared by SE showed a greater dissolution rate during the initial phase of dissolution. Also, after a 12-month follow-up, no significant change was observed in the mentioned parameters. The results of the infrared spectroscopy indicated that there was no chemical interaction between the drug and the polymer. The absence of endotherms related to the pure drug from thermograms of the prepared formulations could be indicative of reduced crystallinity or the gradual dissolving of the drug in the molten polymer. Moreover, formulations prepared by the SE technique revealed superior flowability and compressibility in comparison with the pure drug and physical mixture (ANOVA,   <  0.05).

CONCLUSION

Efficient ternary solid dispersions of glyburide were successfully prepared by F and SE methods. Solid dispersions prepared by SE, in addition to increasing the dissolution properties and the possibility of improving the bioavailability of the drug, showed acceptable long-term physical stability with remarkably improved flowability and compressibility features.

摘要

引言

水溶解度有限以及随之而来的吸收不佳和生物利用度低是口服药物递送中的主要挑战。固体分散体是一种广泛使用的制剂策略,用于克服这一问题。尽管它们效率高,但药物结晶倾向和较差的物理稳定性限制了它们的商业应用。为了克服这一缺陷,采用熔融法(F)和溶剂蒸发法(SE)制备了格列本脲与十二烷基硫酸钠(SLS)和聚乙二醇4000(PEG)的三元固体分散体,随后进行了评估和比较。

材料与方法

采用差示扫描量热法(DSC)、红外光谱法(FTIR)和溶出度试验对制备的三元固体分散体的物理化学和溶出性质进行评估。还使用卡尔指数和豪斯纳比评估流动性。通过比较溶出性质,在初始阶段和12个月后对制剂的物理稳定性进行评估。

结果

与纯药物相比,两种方法制备的制剂在溶出效率和平均溶出时间方面均有显著改善。然而,SE法制备的制剂在溶出初始阶段显示出更高的溶出速率。此外,经过12个月的随访,上述参数未观察到显著变化。红外光谱结果表明药物与聚合物之间没有化学相互作用。制备的制剂热重图中没有与纯药物相关的吸热峰,这可能表明结晶度降低或药物在熔融聚合物中逐渐溶解。此外,与纯药物和物理混合物相比,SE技术制备的制剂显示出更好的流动性和可压缩性(方差分析,P < 0.05)。

结论

通过F法和SE法成功制备了高效的格列本脲三元固体分散体。SE法制备的固体分散体除了提高溶出性质和改善药物生物利用度的可能性外,还显示出可接受的长期物理稳定性,其流动性和可压缩性特征有显著改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e92d/10199792/5c9f5af27f6b/APS2023-2641153.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e92d/10199792/c072d487e841/APS2023-2641153.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e92d/10199792/b3c3b7dc887f/APS2023-2641153.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e92d/10199792/40efee7da5cf/APS2023-2641153.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e92d/10199792/5c9f5af27f6b/APS2023-2641153.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e92d/10199792/c072d487e841/APS2023-2641153.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e92d/10199792/b3c3b7dc887f/APS2023-2641153.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e92d/10199792/40efee7da5cf/APS2023-2641153.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e92d/10199792/5c9f5af27f6b/APS2023-2641153.004.jpg

相似文献

1
Stability-Enhanced Ternary Solid Dispersions of Glyburide: Effect of Preparation Method on Physicochemical Properties.格列本脲稳定性增强的三元固体分散体:制备方法对其理化性质的影响
Adv Pharmacol Pharm Sci. 2023 May 11;2023:2641153. doi: 10.1155/2023/2641153. eCollection 2023.
2
Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.洛伐他汀与聚乙二醇4000和聚乙烯吡咯烷酮K30固体分散体的物理化学表征及溶出度研究
Pharm Dev Technol. 2007;12(1):21-33. doi: 10.1080/10837450601166510.
3
Formulation and evaluation of fast dissolving tablet containing domperidone ternary solid dispersion.含多潘立酮三元固体分散体的速溶片的制备与评价
Int J Pharm Investig. 2014 Oct;4(4):174-82. doi: 10.4103/2230-973X.143116.
4
Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.罗非昔布-聚乙二醇4000固体分散体及基于固体分散体的片剂的特性
Pharm Dev Technol. 2005;10(4):467-77. doi: 10.1080/10837450500299701.
5
Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions.地西泮和替马西泮在聚乙二醇6000固体分散体中溶出度增加的机制。
Int J Pharm. 2002 Dec 5;249(1-2):45-58. doi: 10.1016/s0378-5173(02)00532-x.
6
Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG 6000 and surfactants.基于与聚乙二醇6000和表面活性剂的三元固体分散体的格列本脲速溶片。
Drug Deliv. 2007 Apr;14(4):247-55. doi: 10.1080/10717540601067802.
7
Development and physicochemical characterization of sirolimus solid dispersions prepared by solvent evaporation method.溶剂蒸发法制备西罗莫司固体分散体的研制及其物理化学表征
Adv Pharm Bull. 2014 Dec;4(4):369-74. doi: 10.5681/apb.2014.054. Epub 2014 Aug 10.
8
Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers.使用固体分散体和增溶剂提高硝苯地平的溶出度和生物利用度。
Drug Dev Ind Pharm. 2002 Aug;28(7):795-807. doi: 10.1081/ddc-120005625.
9
Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion.羟丙甲纤维素和聚山梨酯 80 对载有依泽替米贝固体分散体的理化性质和生物利用度的影响。
Carbohydr Polym. 2015 Oct 5;130:26-31. doi: 10.1016/j.carbpol.2015.04.071. Epub 2015 May 12.
10
To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.提高难溶性药物的溶出速率:盐酸氨基葡萄糖作为固体分散体制剂中的潜在载体。
Colloids Surf B Biointerfaces. 2010 Mar 1;76(1):170-8. doi: 10.1016/j.colsurfb.2009.10.030. Epub 2009 Nov 11.

引用本文的文献

1
Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo pharmacokinetics in mice.用于治疗囊性纤维化的可注射长效伊伐卡托载聚(乳酸-共-乙醇酸)微球制剂:体外特征和在小鼠体内的药代动力学。
Int J Pharm. 2024 Jan 25;650:123693. doi: 10.1016/j.ijpharm.2023.123693. Epub 2023 Dec 9.

本文引用的文献

1
Considerations in the Development of Physically Stable High Drug Load API- Polymer Amorphous Solid Dispersions in the Glassy State.在玻璃态下开发物理稳定的高载药量 API-聚合物无定形固体分散体时需要考虑的因素。
J Pharm Sci. 2023 Jan;112(1):8-18. doi: 10.1016/j.xphs.2022.08.007. Epub 2022 Aug 7.
2
Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.羟丙甲纤维素醋酸琥珀酸酯作为一种非凡的聚合物在无定形固体分散体配方中的应用:从实验室到临床的综述。
Eur J Pharm Biopharm. 2022 Aug;177:289-307. doi: 10.1016/j.ejpb.2022.07.010. Epub 2022 Jul 21.
3
Compression of amorphous solid dispersions prepared by hot-melt extrusion, spray drying and vacuum drum drying.
通过热熔挤出、喷雾干燥和真空转鼓干燥制备的无定形固体分散体的压制。
Int J Pharm X. 2021 Nov 3;3:100102. doi: 10.1016/j.ijpx.2021.100102. eCollection 2021 Dec.
4
Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies.药物非晶态固体分散体:制备策略综述
Acta Pharm Sin B. 2021 Aug;11(8):2505-2536. doi: 10.1016/j.apsb.2021.05.014. Epub 2021 Jun 5.
5
Enhancing the water-solubility of curcuminoids-rich extract using a ternary inclusion complex system: Preparation, characterization, and anti-cancer activity.使用三元包合体系增强姜黄素类物质丰富提取物的水溶性:制备、表征和抗癌活性。
Food Chem. 2022 Jan 30;368:130827. doi: 10.1016/j.foodchem.2021.130827. Epub 2021 Aug 10.
6
Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers.三元无定形固体分散体中的药物晶体生长:表面活性剂和聚合物基质载体的影响。
Int J Pharm X. 2021 Jun 5;3:100086. doi: 10.1016/j.ijpx.2021.100086. eCollection 2021 Dec.
7
Combined Self-Nanoemulsifying and Solid Dispersion Systems Showed Enhanced Cinnarizine Release in Hypochlorhydria/Achlorhydria Dissolution Model.联合自纳米乳化和固体分散系统在胃酸过少/无胃酸溶解模型中显示出增强的桂利嗪释放。
Pharmaceutics. 2021 Apr 28;13(5):627. doi: 10.3390/pharmaceutics13050627.
8
Predicting process design spaces for spray drying amorphous solid dispersions.预测喷雾干燥无定形固体分散体的工艺设计空间。
Int J Pharm X. 2021 Feb 25;3:100072. doi: 10.1016/j.ijpx.2021.100072. eCollection 2021 Dec.
9
Hot-Melt Extruded Amorphous Solid Dispersion for Solubility, Stability, and Bioavailability Enhancement of Telmisartan.热熔挤出无定形固体分散体用于提高替米沙坦的溶解度、稳定性和生物利用度
Pharmaceuticals (Basel). 2021 Jan 18;14(1):73. doi: 10.3390/ph14010073.
10
Continuous Formulation Approaches of Amorphous Solid Dispersions: Significance of Powder Flow Properties and Feeding Performance.无定形固体分散体的连续制剂方法:粉末流动性质和进料性能的意义。
Pharmaceutics. 2019 Dec 5;11(12):654. doi: 10.3390/pharmaceutics11120654.